Gene Query: IRF7

Dataset Description Geneva Score
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 184.23
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 184.23
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 135.74
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 128.62
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 119.87
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 104.2
UBC9 knockdown in bladder cancer T24 cell lines 87.31
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 86.71
Macrophage Ad5f35 M2 Challenge 83.18
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 78.71
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 78.71
Expression data from miR340 overexpressing human A549 cells 78.16
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 75.23
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 75.23
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 74.94
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 74.94
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 72.55
Overexpression of NFIB and YBX1 in MCF-7 cells 71.55
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 69.01
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 62.09
Effect of Influenza virus infection on lncRNA expression in A549 cells 61.02
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 60.09
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 58.16
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 58.16
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 57.92
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 57.92
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 55.71
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 54.4
Genome wide expression change by RNF168 knocking down in NEC cells 50.66
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 50.33
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 49.81
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 49.75
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 49.23
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 48.91
LncRNA-GAS5 negative regulation of YAP-target genes expression 47.09
Effects of rFVIIIFc on human macrophages 46.87
Polarized B -cell functions 46.28
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 43.75
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 43.75
Macrophage Ad5f35 PhenoMap 42.74
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 42.28
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 39.2
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 39.2
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 39.02
Paxillin regulates genomic networks in prostate cancer [PC3] 38.79
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 38.41
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 38.41
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 37.4
Transcriptional changes in lymphoma cells induced by LSD1 depletion 37.4
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 36.85
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 36.75
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 34.91
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 34.45
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 34.45
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 34.27
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 34.27
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 33.43
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 32.53
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 31.98
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 30.85
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 29.86
IRF1 regulates IFN dependent and independent gene expression 28.81
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 28.48
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 27.82
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 27.39
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 27.33
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 27.32
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 27.11
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 26.81
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 26.44
Irf9 function in immunity in mouse 26.12
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 26.12
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 25.75
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 25.75
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 25.74
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 25.68
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 25.31
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 25.31
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 24.36
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 24.16
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 24.16
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 23.78
HNF1 regulates critical functions of the human epididymis epithelium. 23.78
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 23.34
Generation and functional characterization of MDSC-like cells 23.27
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 22.72
Survival of pancreatic cancer cells lacking KRAS function 22.59
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 21.84
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 21.8
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 21.51
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 21.37
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 21.37
Global analysis of alternative splicing regulated by RBM10 21.24
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  21.1
CD74 role in transcription regulation 21.06
CD74 role in transcription regulation [RNA-seq] 21.06
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 20.87
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 20.79
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 20.6
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 20.6
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 20.56
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 20.52
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 20.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 19.72
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 19.44
Disruption of the exocyst induces podocyte loss and dysfunction 19.4
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 18.56
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 18.47
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 18.45
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 18.43
Pharmacologic inhibition of STAT5 in AML 18.32
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 18.23
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 18.17
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 18.12
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 18.07
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 18.0
NAPRT activation of macrophages 17.72
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 17.6
The role of the Calcium-Sensing receptor in colorectal cancer 17.46
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 17.37
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 17.36
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 17.05
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 16.97
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 16.97
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 16.8
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 16.8
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 16.79
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 16.78
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 16.65
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 16.6
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 16.6
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 16.57
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 16.57
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 16.39
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 16.28
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 15.99
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 15.99
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 15.95
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 15.91
Silencing p300 in MCF7 cells to study expression and alternative splicing 15.78
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 15.7
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 15.7
The cytokine environment influence on human skin-derived T cells 15.37
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 15.35
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 15.35
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 15.06
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 15.02
Landscape of H3K4me3 in human CD19 cells 14.81
Primary human trophoblast from term placenta 14.77
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 14.71
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 14.67
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 14.66
The comparison of high-throughput single-cell RNA-seq methods 14.59
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 14.58
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 14.58
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 14.33
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 14.31
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 13.84
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 13.79
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.72
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 13.7
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 13.7
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 13.66
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 13.64
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 13.47
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 13.4
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 13.4
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 13.31
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 13.31
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 13.19
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 13.19
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 13.11
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 13.11
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 13.02
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 12.93
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 12.93
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 12.93
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 12.87
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 12.87
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 12.86
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 12.52
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 12.52
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 12.42
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 12.41
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 12.35
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 12.35
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 12.32
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 12.15
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 12.15
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 12.08
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 12.05
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 12.04
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 12.03
LIN28A modulates splicing and gene expression programs in breast cancer cells 11.91
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 11.91
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 11.88
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 11.81
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 11.79
Region-specific Innate Antiviral Responses of the Human Epididymis 11.69
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 11.67
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 11.62
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 11.62
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 11.49
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 11.48
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 11.4
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 11.32
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 11.31
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 11.29
snRNAs as regulators of alternative splicing 11.27
Transcriptome-wide identification of CELF2 functional targets in T cells 11.22
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 11.21
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 11.17
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 11.15
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 11.15
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 10.97
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 10.97
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 10.9
Overexpression and knockdown experiment for circCSNK1G3 10.64
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.6
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 10.6
Trans-differentiation of human adult peripheral blood T cells into neurons 10.54
Transcriptomes of human monocytes after ex vivo exposure to uric acid 10.5
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.5
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 10.49
Intrahepatic MAIT cell gene expression revealed by RNA-seq 10.49
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 10.44
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 10.41
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 10.25
Intron retention induced by microsatellite expansions as a disease biomarker. 10.2
Gene Expression Profiling of WT and KDM3A Knocked out Cell 10.13
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 10.13
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 10.09
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.06
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 9.99
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 9.99
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.82
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.82
RIG-I and MDA5 fRIP during KSHV lytic reactivation 9.8
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.61
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 9.6
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 9.6
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 9.55
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 9.5
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 9.49
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 9.48
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 9.46
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.41
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 9.41
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 9.37
LNCaP treated with iBET 9.35
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 9.29
Transcriptional responses of human insulinoma cells to acute cytokine exposure 9.26
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 8.88
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.78
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 8.76
Transcriptome Profiling of Human Primary Monocytes 8.7
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 8.65
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 8.59
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 8.59
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.54
IRF2 is a master regulator of human keratinocyte stem cell fate 8.54
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 8.47
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 8.43
Total RNA-seq in ALL-SIL upon JQ1 inhibition 8.38
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 8.38
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.34
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 8.27
Transcriptome wide analysis of classically and alternatively activated macrophages 8.18
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 8.14
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.13
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 8.11
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 7.97
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.9
Differential responses of human fetal brain neural stem cells to Zika virus infection 7.81
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 7.75
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.74
CSL 7.63
CSL RNA-Seq on HKC and SCC cell lines 7.63
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 7.58
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 7.54
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.45
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 7.39
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.34
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 7.33
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.29
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 7.27
Transcriptome analysis of virus infected tissues 7.19
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.18
Zone dependent distinctive gene expression profile of the normal human liver tissue 7.14
Generation of trichogenic adipose-derived stem cells by expression of three factors 7.05
RNA-seq of MCF10A cells and CAF 6.95
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.87
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.87
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 6.84
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.83
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 6.82
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.81
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.81
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.7
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 6.67
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.65
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 6.62
Characterization of human ILC2 subsets 6.58
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 6.55
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 6.47
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 6.47
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 6.35
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.33
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 6.23
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 6.14
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.11
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 6.04
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.03
Generation of KRAS signatures using immortalized isogenic lung cells. 6.01
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 5.86
RNA seq with AML (NB4) cells upon FTO inhibition 5.82
Dermal endothelial cells of type 2 diabetic patients 5.78
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.77
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.77
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 5.77
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 5.75
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 5.74
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 5.74
Be1 and Be2 B cells are transcriptionally distinct 5.69
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.67
RNA Seq of HMVEC under hypoxia 5.65
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.65
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.64
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 5.59
LncRNA expression profiling of ischemic stroke patients 5.57
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.57
Transcription elongation regulates genome 3D structure 5.54
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 5.5
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 5.46
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 5.35
Efficient derivation of microglia-like cells from human pluripotent stem cells 5.33
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.32
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  5.31
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.31
Gene expression of thyroid cancer cell lines 5.25
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.2
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 5.18
Fbxo32 mediated gene expression program underlies EMT and metastasis 5.14
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 5.07
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 5.07
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.83
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 4.75
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 4.75
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 4.7
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 4.7
Leucegene: ALL sequencing 4.66
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.59
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 4.58
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 4.5
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.49
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.47
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.41
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.4
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 4.38
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.38
Proliferation-correlated expression 4.31
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.3
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 4.2
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.2
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.16
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 4.15
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 4.15
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.15
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.15
RNA-sequencing in immortalized human mammary epithelial cells 4.15
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 4.15
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 4.11
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.09
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 4.08
Transcriptional profile in human S. haematobium infection 4.07
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.01
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.95
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.85
MARCKS and lnc-MARCKS act as inflammation regulators 3.76
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.72
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.63
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.59
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 3.52
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.49
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.47
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.47
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 3.39
MRTF activates TEAD-YAP target gene expression 3.38
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 3.32
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.31
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 3.27
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 3.27
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.07
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.95
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 2.95
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.9
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.89
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.86
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.8
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.77
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.76
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.74
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.69
BACH2 in human plasma cell fate decision 2.68
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.66
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.57
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.57
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.56
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.56
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.55
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.49
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.49
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.44
Single-cell analysis of adult human ovary using 10X genomics 2.44
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.43
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.42
Anti-inflammatory effect of indoleacrylic acid (IA) 2.42
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.4
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.35
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.33
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.33
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.32
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.32
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.3
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.3
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.29
naive T cell heterogeneity after neonatal thymectomy 2.25
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.25
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.22
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.22
circRNA profile in hypopharyngeal cancer 2.21
MicroRNA targetome analysis during HCMV infection 2.21
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.18
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.16
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.16
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 2.03
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.99
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.98
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.98
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.96
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.92
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.89
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.82
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.82
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.76
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.74
MYCi975 regulates MYC target genes 1.72
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.7
RNA sequencing of human pancreatic cancer cell lines 1.56
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.55
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.52
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.5
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.39
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.38
Primary Human B-cell Temporal Response to CD40L Stimulation 1.3
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.23
Tpl-2 and MEK small molecule inhibitors 1.21
Tpl-2 small molecule project 1.21
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.18
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.18
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.16
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.1
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.97
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.96
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.96
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.9
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.9
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.9
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.84
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.82
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 0.71
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.7
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.69
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.64
Investigate A2M treatment on human prostate cancer xenograft in mice 0.54
Investigate A2M treatment on human prostate cancer and mouse liver 0.54
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.52
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.49
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.49
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.46
The pioneer factor CEBPA modulates vitamin D signaling 0.46
miRNAs affected by antagomiR-17 treatment 0.46
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.42
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.4
Transcriptomic analysis of human macrophages in 3D 0.35
Transcriptomes in healthy and CHB fetal hearts 0.35
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.27
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.21
Specific molecular signatures underlie response to decitabine in CMML 0.21
BASP1 modifies the Tamoxifen response 0.2
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.19
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.18
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.15
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.13
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.11
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.1
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.08
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.02
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation